|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1F30CA290816-01A1 |
Evaluating Antigen Spread After cDC1 Vaccination |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$37,598 |
|
$37,598 |
| 1F31CA298051-01 |
Dissecting the role of gut microbiome dysbiosis in lung cancer development and progression. |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$37,598 |
|
$37,598 |
| 1F31CA298677-01 |
Investigating the role of CARM1-mediated methylation of Qki in glioblastoma |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$37,598 |
|
$37,598 |
| 1F31CA305956-01 |
129Xe Hyperpolarized Chemical Exchange Saturation Transfer (HyperCEST) MRI for Tracking Immunotherapy Delivery in the Lungs |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$37,613 |
|
$37,613 |
| 1F31HL176043-01A1 |
Dependence of radiosensitivity of lymphocyte subtypes on proton dose and LET and its impact on immune suppression |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NHLBI |
$37,598 |
|
$37,598 |
| 1F32CA301661-01 |
Evolution and clinical significance of complex genome rearrangements |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$75,052 |
|
$75,052 |
| 1F99CA305489-01 |
Modulation of intracellular lipid access by ATGL determines ferroptosis sensitivity in castration-resistant prostate cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$39,203 |
|
$39,203 |
| 1K01AI192505-01 |
When molds go viral: Dissecting the pathogenesis of post-viral Aspergillus pneumonias to guide immunomodulatory therapy in immunocompromised hosts |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIAID |
$140,831 |
$11,266 |
$152,097 |
| 1K01CA297060-01A1 |
Decoding Mosaic Chromosomal Alterations in Lymphoid Malignancy Risk and Outcomes |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$178,000 |
$14,240 |
$192,240 |
| 1K08CA293160-01A1 |
Evaluating Dietary Change and a Mediterranean Diet Intervention Among Medically Underserved Men with Prostate Cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$194,447 |
$15,556 |
$210,003 |
| 1K08CA296776-01 |
Harnessing ecDNA Detection in Antigen-Presenting Cells for Anti-Tumor Immunity |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$128,932 |
$10,315 |
$139,247 |
| 1K22CA276360-01 |
Unraveling the functional contribution of extracellular vesicles in pancreatic cancer |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$178,000 |
$14,240 |
$192,240 |
| 1K23HL175243-01A1 |
Hyperpolarized Xenon-129 MRI as a predictive biomarker for mitigating radiation-induced lung injury |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NHLBI |
$177,697 |
$14,216 |
$191,913 |
| 1K99CA286745-01A1 |
Mechanisms of CDH1-inactivated advanced gastric adenocarcinoma tumorigenesis |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$116,466 |
$9,317 |
$125,783 |
| 1K99CA296780-01 |
The role of oral microbiota in metastatic brain tumors |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$103,728 |
$8,298 |
$112,026 |
| 1K99CA296940-01 |
Adverse gut microbiome promotes resistance immune checkpoint inhibitors via chronic inflammation |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$30,000 |
$2,400 |
$32,400 |
| 1P01CA278716-01A1 |
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$1,463,306 |
$929,199 |
$2,392,505 |
| 1P01CA296429-01A1 |
Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy. |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$1,457,433 |
$651,301 |
$2,108,734 |
| 1P50CA302482-01 |
MD Anderson Sarcoma SPORE |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NCI |
$1,117,649 |
$706,971 |
$1,824,620 |
| 1R01AI183604-01A1 |
Role of GRAIL in B cell tolerance and B-cell mediated inflammation |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
NIAID |
$2,005,010 |
$1,283,205 |
$3,288,215 |